Merel E P Wilmsen Selected Research

Pancreatic Neoplasms (Pancreatic Cancer)

1/2023

Overcoming immune checkpoint blockade resistance in solid tumors with intermittent ITK inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Merel E P Wilmsen Research Topics

Disease

3	Neoplasms (Cancer) 12/2023 - 01/2023
2	Melanoma (Melanoma, Malignant) 12/2023 - 01/2023
2	Mesothelioma 12/2023 - 01/2023
1	Bites and Stings (Sting) 12/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023
1	COVID-19 01/2022

Drug/Important Bio-Agent (IBA)

3	Immune Checkpoint InhibitorsIBA 12/2023 - 01/2023
1	cyclic diadenosine phosphateIBA 12/2023
1	Peptides (Polypeptides)IBA 12/2023
1	VaccinesIBA 12/2023
1	OligodeoxyribonucleotidesIBA 12/2023
1	emt protein-tyrosine kinase (IL2-inducible T-cell kinase)IBA 01/2023
1	ibrutinibIBA 01/2023
1	AntigensIBA 01/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	CytokinesIBA 01/2022

Therapy/Procedure

3	Immunotherapy 12/2023 - 01/2023
3	Therapeutics 01/2023 - 01/2022